Medtronic plc — Director's Dealing 2021

Aug 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-08-02

Reporting Person: Kuntz Richard (SVP & Chief Medical & Science)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-02	Ordinary Shares	F	4905	$131.31	Disposed	69886	Direct
2021-08-02	Ordinary Shares	A	5029	—	Acquired	74915	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-02	Stock Option (Right to Buy)	$131.26	A	42961	Acquired	2031-08-02	Ordinary Shares (42961)	Direct
2021-08-02	Stock Option (Right to Buy)	$131.26	A	1085	Acquired	2031-08-02	Ordinary Shares (1085)	Direct
2021-08-02	Performance Share Units	$	A	12571	Acquired		Performance Share Units (12571)	Direct

Footnotes

F1: This balance increased by 782 shares due to exempt transactions such as dividend reinvestment.

F2: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F3: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

F4: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F5: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 12,571 shares will be issued. The actual number of shares to be issued could range from a low of 2,515 at minimum performance to a high of 25,142 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

F6: Vests on August 2, 2024.